Please use this identifier to cite or link to this item:
Title: Exploratory analyses to assess the impact of a CMV infection on the immunogenicity of a flu vaccine
Authors: Agbor, Geraldine Manyi
Advisors: BURZYKOWSKI, Tomasz
DEWE, Walthère
Issue Date: 2012
Publisher: tUL Diepenbeek
Abstract: Introduction: Influenza virus infection, caused by influenza viruses, is a worldwide, highly contagious respiratory disease that is self-limiting in immunocompetent persons but life-threatening in immunocompromised subjects as well as in the older population. Of interest to the public health are H1N1 and H3N2 and the B strains of the virus. Research has shown that younger subjects respond better to influenza vaccines than the elderly. There are speculations that pathogens like the cytomegalovirus (CMV) may influence the response to influenza vaccine. The objective of this study is to investigate the relationship between the CMV status and response to the influenza vaccines; and to assess whether the response varies from one treatment group to another. Data and method: The data contains measurements for hemagglutinin inhibition serological tests based on ELISA technique to determine the CMV. Measurements of the response to the vaccine were based on seroconversion, seroprotection and Geometric Mean Titers (GMT). Exploratory analyses were carried out using test statistics, graphical techniques, Linear mixed models and Logistic regression. Result: Exploratory analyses with test statistics and graphical techniques revealed a potential difference between CMV seropositive and seronegative subjects in the response to influenza vaccine. Logistic regression models based on seroconversion provided evidence of an association between the CMV status and the response to influenza vaccine for strains H1N1 and B. Results from the linear mixed models provided evidence that the response to influenza vaccine varies between the treatment groups. Conclusion: CMV seronegative subjects respond better to influenza vaccines than CMV seropositive subjects for strains H1N1 and B based on the seroconversion seroresponse. Response to the influenza vaccine varies between treatment groups based on the GMT seroresponse.
Notes: Master of Statistics-Biostatistics
Document URI:
Category: T2
Type: Theses and Dissertations
Appears in Collections:Master theses

Files in This Item:
File Description SizeFormat 
09289892011005.pdf1.84 MBAdobe PDFView/Open
Show full item record

Page view(s)

checked on May 20, 2022


checked on May 20, 2022

Google ScholarTM


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.